TTOO longI open a long position here but only a small position and going to be cautious and keep and eye on it. Feel like im chasing a bit here but I think this has plenty of room to run so lets see.
0%
0%
0%
0%
0%
−5.7487USD
−62.003MUSD
22.305MUSD
292.433M
About T2 Biosystems, Inc.
Sector
Industry
CEO
John J. Sperzel
Website
Headquarters
Lexington
Employees
158
Founded
2006
ISIN
US89853L2034
T2 Biosystems, Inc. engages in the development of a proprietary technology platform. It offers the T2 Magnetic Resonance technology, which enables detection of pathogens, biomarkers, and other abnormalities in a range of unpurified patient sample types. The firm's products include the T2Dx Instrument, the T2Candida Panel, the T2Bacteria Panel, the T2Resistance Panel, and the T2SARS-CoV-2 Panel. The company was founded by Michael J. Cima, Robert S. Langer Jr., Tyler Jacks, Lee Josephson, W. David Lee, and Ralph Weissleder on April 27, 2006 and is headquartered in Lexington, MA.
T2 Biosystems IncThis may the bottom on the double. Keep on watch. I think there’s a good chance it skyrockets parabolic. Goodluck.
$TTOO Septic GrowthSepsis may seem like a concern of the past, something that barely affects society ever since medical communities stopped believing that puss was part of the natural healing process. That notion is far from the truth since it is estimated that 30%-50% of hospital deaths are due to sepsis. T2 Biosyste
TTOO T2 Biosystems Options Ahead of EarningsLooking at the TTOO T2 Biosystems options chain, i would buy the $2.5 strike price Calls with
2023-5-19 expiration date for about
$1.20 premium.
If the options turn out to be profitable Before the earnings release, i would sell at least 50%.
Looking forward to read your opinion about it.
Buy TTOO@ 0.14 Target $3.00 Nov 17, 2023TTOO -T2 Biosystems
Old School Pump and dump stock
Technical Anaylsis/ Volume Leader
1. Break below the support
2. Had a mini bull run
3. Pull-back to about $0.014 or below
4. Buy the dip @ $0.14 or better
5. Target @ $3.00 if lucky Nov 17, 2023 to complete cycle
6. Long target to $0.01 on
T2 Biosystems Long Term 2023 Target $22T2 Biosystems Revenue for Q3 2021 was exceptionally good.
Expecting $5.48 by end of 2021/Q1-2022, followed by $22 by 2023 long term.
#t2biosystems
TTOOAppears to have bottomed here and corrections are zig zig patterns 5,3,5 that continue to overlap into each other so I labeled this correction with WXY. Most likely TTOO will push back up from here towards $1.40
TtooIf anyone watched or had been subscribed to my channel. Last year we loaded TTOO up at 1.07$. We ran it up to 2.60-3$ level and dumped it. There was no news around 1.07$ however nees came out on a covid approval around 2.45$ and shortly after dumped right along the time of the news….
I’m seeing s
TTOOT2 Biosystems Inc (NASDAQ:TTOO) displayed relative strength on Friday closing above its 50-day exponential moving average for the first time since March. If the stock price remains above this level, investors will assess this development as a sign of strength. From the technical analysis perspective
$TTOO taking it's time but on track!$TTOO unfortunately did what was expected and broke down out of the descending triangle. It's still on track and once it breaks through the 236 I'll be happier and add some more call options.
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
